Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-04-17

Clinical Trial Update: Does PTH 1-34 (Teriparatide) Enhance Spinal Fusion in Humans? [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating whether PTH 1-34 (teriparatide) enhances spinal fusion in humans with spinal stenosis has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PTH 1-34 (Teriparatide) (teriparatide)

Snippet

Sponsor: University Hospital, Linkoeping | Conditions: Spinal Stenosis | Phase 4 | Status: COMPLETED